Abstract:Background: Congenital heart disease (CHD) is the most common congenital anomaly. Up to 33% have an identifiable genetic etiology. Improved medical and surgical management of CHD has translated into longer life expectancy and a rapidly growing population of adults living with CHD. The adult CHD (ACHD) population did not have access during childhood to the genetic technologies available today and therefore have not had a robust genetic evaluation that is currently recommended for infants with CHD. Given this potential benefit; the aims of this study were to determine how ACHD cardiologists offer genetics services to patients and identify the indications that influence decision-making for genetics care. Methods: We performed a descriptive cross-sectional study of ACHD cardiologists. A study-developed questionnaire was distributed via emailed REDCap link. The recruitment email was sent to 104 potential respondents. The survey was open from 06/2022 to 01/2023. Results: Thirty-five cardiologists participated in the study (response rate of 34%). Most cardiologists identified as white (77%) and male (66%). Cardiologists were more likely to refer patients to genetics (91%) than to order testing themselves (57%). Of the testing ordered, chromosomal testing (55%) was ordered more than gene sequencing (14%). Most cardiologists would refer a patient with a conotruncal lesion (interrupted aortic arch) over other indications for a genetics evaluation. There were more reported barriers to ordering genetic testing (66%) compared to referring to genetics for a genetics evaluation (23%). Cardiologists were more confident recognizing features suggestive of a genetic syndrome than ordering the correct test ( p = 0.001). Regarding associations between clinical factors and current practices, more years in practice trended towards less referrals and testing. Evaluating a greater number of patients ( p = 0.11) and greater confidence recognizing syndromic features ( p = 0.12) and ordering the correct test ( p = 0.09) were all associated with ordering more testing. Conclusion: Testing for microdeletion syndromes is being offered and completed in the ACHD population, however testing for single-gene disorders associated with CHD is being under-utilized. Developing guidelines for genetic testing in adults with CHD could increase access to genetic services, impact medical management, reduce uncertainty regarding prognosis, and inform recurrence risk estimates.

Genomic testing and molecular diagnosis among infants with congenital heart disease in the neonatal intensive care unit

Clinical Genetic and Genomic Testing in Congenital Heart Disease and Cardiomyopathy

Clinical Decision Analysis of Genetic Evaluation and Testing in 1013 Intensive Care Unit Infants with Congenital Heart Defects Supports Universal Genetic Testing

Progresses in Genetic Testing in Congenital Heart Disease

Epidemiology, Prenatal Diagnosis, and Neonatal Outcomes of Congenital Heart Defects in Eastern China: a Hospital-Based Multicenter Study

Genetic Architecture in Neonatal Intensive Care Unit Patients with Congenital Heart Defects: a Retrospective Study from the China Neonatal Genomes Project.

Current approach to genetic testing and genetic evaluation referrals for adults with congenital heart disease

The Impact of Integration of a Genetic Clinic Into a Pediatric Cardiac Unit

[Specification for Genetic Diagnosis of Congenital Heart Disease].

Genetic investigation and diagnosis in adults with congenital heart disease with or without structural or neurodevelopmental comorbidity: a retrospective chart review

Timing and Mode of Delivery in Prenatally Diagnosed Congenital Heart Disease- an Analysis of Practices within the University of California Fetal Consortium (UCfC)

Contemporary prenatal diagnosis of congenital heart disease in a regional perinatal center lacking onsite pediatric cardiac surgery: obstetrical and neonatal outcomes

Rapid Genome Sequencing Shows Diagnostic Utility In Infants With Congenital Heart Defects

Chromosome Microarray Testing for Patients with Congenital Heart Defects Reveals Novel Disease Causing Loci and High Diagnostic Yield

Genetic Contribution to Congenital Heart Disease (CHD)

Variation in Prenatal Diagnosis of Congenital Heart Disease in Infants

Preschool Neurodevelopmental Outcomes in Children with Congenital Heart Disease

Growth and risk of adverse neuro-developmental outcome in newborns with congenital heart disease: A single-centre retrospective study

Clinical profile of congenital heart diseases detected in a tertiary hospital in China: a retrospective analysis

Neonatal outcomes in preterm infants with severe congenital heart disease: a national cohort analysis

Rapid whole genome sequencing impacts care and resource utilization in infants with congenital heart disease